# Micro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction

Study · id `cardio:ct-nct07678021` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07678021](<https://clinicaltrials.gov/study/NCT07678021>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07678021

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 452 participants.

## Technical summary

Registry record NCT07678021. Randomized; double masking; primary purpose treatment. Start 2026-08-01 (anticipated); primary completion 2029-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 452 participants (planned count; ClinicalTrials.gov record NCT07678021, source copy `cardio:ctgov-nct07678021-2026-07-01`, retrieved 2026-10-26)
- Planned start: 2026-08-01 (anticipated) (ClinicalTrials.gov record NCT07678021, source copy `cardio:ctgov-nct07678021-2026-07-01`, retrieved 2026-10-26)
- Primary completion: 2029-12-31 (anticipated) (ClinicalTrials.gov record NCT07678021, source copy `cardio:ctgov-nct07678021-2026-07-01`, retrieved 2026-10-26)
- Completion: 2029-12-31 (anticipated) (ClinicalTrials.gov record NCT07678021, source copy `cardio:ctgov-nct07678021-2026-07-01`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07678021, source copy `cardio:ctgov-nct07678021-2026-07-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07678021-2026-07-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Micro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction
- Acronym: PIVOT
- Condition: Coronary Artery Disease (CAD)
- Intervention (Device): Microaxial pump-supported PCI
- Intervention (Drug): Optimal medical therapy (OMT)
- Lead sponsor: China National Center for Cardiovascular Diseases
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: China National Center for Cardiovascular Diseases (`cardio:org-china-national-center-for-cardiovascular-diseases`)

## Provenance

Content hash: c8a38eba3b16f2a4a556890a5ce6ec063b101186915da4f746b5c88b6ee9ae08
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
